Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles
- 30 August 2011
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 415 (1-2), 244-251
- https://doi.org/10.1016/j.ijpharm.2011.05.046
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different StabilizersPLOS ONE, 2011
- Increased Numbers of Injections of Doxorubicin Bound to Nanoparticles Lead to Enhanced Efficacy Against Rat Glioblastoma 101/8Journal of Nanoneuroscience, 2009
- Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effectsClinical Neuropathology, 2009
- Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy ratsToxicology Letters, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Serum GFAP is a diagnostic marker for glioblastoma multiformeBrain, 2007
- Analysis of Prion Strains by PrPSc Profiling in Sporadic Creutzfeldt–Jakob DiseasePLoS Medicine, 2005
- Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivoJournal of Hepatology, 2005
- Primary brain tumours in adultsThe Lancet, 2003
- HPLC methods for the determination of bound and free doxorubicin, and of bound and free galactosamine, in methacrylamide polymer-drug conjugatesJournal of Pharmaceutical and Biomedical Analysis, 1996